Nakano Masahiro, Yamamoto Yutaka, Kawasoe Teru, Hayashi Mitsuhiro, Sueta Aiko, Honda Yumi, Iyama Kenichi, Iwase Hirotaka
Dept. of Breast and Endocrine Surgery, Kumamoto University Hospital, Japan.
Gan To Kagaku Ryoho. 2009 Jun;36(6):1017-9.
A 57-year-old woman complained of a huge and rapid growing mass with bleeding in the left breast. Breast imaging (CT and MRI)showed a large, irregular and unevenly enhanced tumor with lymph node swelling in the left axilla. Mastectomy and axillary lymph node dissection were performed for control of bleeding from the tumor in the left breast. Pathological diagnosis was spindle cell carcinoma of the breast with transition from papillotubular carcinoma. Although the patient was treated with adjuvant chemotherapy and trastuzumab according to the treatment guideline for conventional breast cancer, she had an early relapse with mediastinal metastasis and died 9 months after operation. The tumor showed metaplastic change from epithelial tumor to spindle cell carcinoma. Because the epithelial part expressed weakly positive estrogen receptor(ER), progesterone receptor(PgR)-negative and HER2-positive, we used trastuzumab for adjuvant therapy. However, part of the spindle cell tumor mainly showed triple-negative, and ER, PgR and HER2 expression were negative, which might explain her poor prognosis for resistance to trastuzumab.
一名57岁女性主诉左乳有一个巨大且生长迅速的肿物伴出血。乳腺影像学检查(CT和MRI)显示左乳有一个大的、不规则且强化不均匀的肿瘤,左侧腋窝淋巴结肿大。为控制左乳肿瘤出血,进行了乳房切除术和腋窝淋巴结清扫术。病理诊断为乳腺梭形细胞癌,由乳头管状癌转变而来。尽管根据传统乳腺癌治疗指南对该患者进行了辅助化疗和曲妥珠单抗治疗,但她仍早期复发并出现纵隔转移,术后9个月死亡。肿瘤显示出从上皮性肿瘤向梭形细胞癌的化生改变。由于上皮部分雌激素受体(ER)呈弱阳性、孕激素受体(PgR)阴性且HER2阳性,我们使用曲妥珠单抗进行辅助治疗。然而,部分梭形细胞瘤主要表现为三阴性,ER、PgR和HER2表达均为阴性,这可能解释了她对曲妥珠单抗耐药且预后较差的原因。